Patents by Inventor Lucius Kemp

Lucius Kemp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7348340
    Abstract: Compounds useful for the treatment of pain in accord with the following structural diagram, wherein R1, R2 and R3 are any of a number of groups as defined in the specification and pharmaceutical compositions and methods of treatment utilising such compounds.
    Type: Grant
    Filed: August 23, 2006
    Date of Patent: March 25, 2008
    Assignee: AstraZeneca AB
    Inventors: Marc Chapdelaine, Lucius Kemp, John McCauley
  • Publication number: 20070129363
    Abstract: Compounds useful for the treatment of pain in accord with the following structural diagram, wherein R1, R2 and R3 are any of a number of groups as defined in the specification and pharmaceutical compositions and methods of treatment utilising such compounds.
    Type: Application
    Filed: August 23, 2006
    Publication date: June 7, 2007
    Applicant: ASTRAZENECA AB
    Inventors: Marc Chapdelaine, Lucius Kemp, John McCauley
  • Patent number: 7189714
    Abstract: Compounds useful for the treatment of pain in accord with the following structural diagram, wherein R1, R2 and R3 are any of a number of groups as defined in the specification and pharmaceutical compositions and methods of treatment utilising such compounds.
    Type: Grant
    Filed: October 31, 2001
    Date of Patent: March 13, 2007
    Assignee: Astrazeneca AB
    Inventors: Marc Chapdelaine, Lucius Kemp, John McCauley
  • Patent number: 6841680
    Abstract: Compounds having selective action at neuronal N-type calcium channels useful for the treatment of pain in accord with the following structural diagram, wherein R1, R2 and R3 are a variety of groups as defined in the specification.
    Type: Grant
    Filed: October 31, 2001
    Date of Patent: January 11, 2005
    Assignee: AstraZeneca AB
    Inventors: Marc Chapdelaine, Lucius Kemp, John McCauley
  • Patent number: 6815447
    Abstract: Compounds useful for the treatment of pain in accord with the following structural diagram, wherein R1, R2 and R3 are any of a number of groups as defined in the specification and pharmaceutical compositions and methods of treatment utilising such compounds.
    Type: Grant
    Filed: October 2, 2003
    Date of Patent: November 9, 2004
    Assignee: Astrazeneca AB
    Inventors: Bipinchandra Chaudhari, Marc Chapdelaine, Greg Hostetler, Lucius Kemp, John McCauley
  • Publication number: 20040077644
    Abstract: Compounds useful for the treatment of pain in accord with the following structural diagram, 1
    Type: Application
    Filed: November 3, 2003
    Publication date: April 22, 2004
    Inventors: Marc Chapdelaine, Lucius Kemp, John McCauley
  • Publication number: 20040058945
    Abstract: Compounds useful for the treatment of pain in accord with the following structural diagram, 1
    Type: Application
    Filed: October 2, 2003
    Publication date: March 25, 2004
    Inventors: Bipinchandra Chaudhari, Marc Chapdelaine, Greg Hostetler, Lucius Kemp, John McCauley
  • Publication number: 20040053965
    Abstract: Compounds having selective action at neuronal N-type calcium channels useful for the treatment of pain in accord with the following structural diagram, 1
    Type: Application
    Filed: October 15, 2003
    Publication date: March 18, 2004
    Inventors: Marc Chapdelaine, Lucius Kemp, John McCauley